AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELUTIA INC. Director's Dealing 2022

Dec 28, 2022

34697_dirs_2022-12-28_c7203bd2-4c7a-490d-9b6c-52fca981a2e7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AZIYO BIOLOGICS, INC. (AZYO)
CIK: 0001708527
Period of Report: 2022-12-22

Reporting Person: HighCape Partners GP II, LLC (N/A)
Reporting Person: HighCape Partners GP II, L.P. (10% Owner)
Reporting Person: HighCape Partners QP II, L.P. (10% Owner)
Reporting Person: HighCape Partners II, L.P. (10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-22	Stock Option (Right to Buy)	$3.80	A	17533	Acquired	2032-12-21	Class A Common Stock (17533)	Indirect

Footnotes

F1: This option vests in full and shall be fully exercisable on June 20, 2023, subject to Mr. Rakin's continuing in service on the Issuer's board of directors through the vesting date.

F2: Granted to Kevin L. Rakin as non-employee member of the Issuer's board of directors.